Tubeimoside-1 induces glioma apoptosis through regulation of Bax/Bcl-2 and the ROS/Cytochrome C/Caspase-3 pathway

Abstract

These findings indicate that TBMS1 may be developed as a possible therapeutic agent for the management of glioma.